Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 00025/0372.
Maxalt Melt 10 mg oral lyophilisates
MAXALT® MELT 10 mg Oral Lyophilisate
rizatriptan
1. What MAXALT MELT is and what it is used for
2. What you need to know before you take MAXALT MELT
3. How to take MAXALT MELT
4. Possible side effects
5. How to store MAXALT MELT
6. Contents of the pack and other information
MAXALT MELT belongs to a class of medicines called selective serotonin 5-HT1B/1D receptor agonists.
MAXALT MELT is used to treat the headache phase of the migraine attack in adults.
Treatment with MAXALT MELT:
Reduces swelling of blood vessels surrounding the brain. This swelling results in the headache pain of a migraine attack.
If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking MAXALT MELT.
Talk to your doctor or pharmacist before taking MAXALT MELT, if:
If you take MAXALT MELT too often this may result in you getting a chronic headache. In such cases you should contact your doctor as you may have to stop taking MAXALT MELT.
Tell your doctor or pharmacist about your symptoms. Your doctor will decide if you have migraine. You should take MAXALT MELT only for a migraine attack. MAXALT MELT should not be used to treat headaches that might be caused by other, more serious conditions.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This includes herbal medicines and those you normally take for a migraine. This is because MAXALT MELT can affect the way some medicines work. Also, other medicines can affect MAXALT MELT.
Do not take MAXALT MELT:
The above listed medicines when taken with MAXALT MELT may increase the risk of side effects.
You should wait at least 6 hours after taking MAXALT MELT before you take ergotamine-type medications such as ergotamine or dihydro-ergotamine or methysergide.
You should wait at least 24 hours after taking ergotamine-type medications before taking MAXALT MELT.
Ask your doctor for instructions and the risks about taking MAXALT MELT
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
MAXALT MELT can take longer to work if it is taken after food. Although it is better to take it on an empty stomach, you can still take it if you have eaten.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Available data on the safety of rizatriptan when used during the first 3 months of pregnancy do not suggest an increased risk of birth defects. It is not known whether MAXALT MELT is harmful to an unborn baby when taken by a pregnant woman after the first 3 months of pregnancy.
If you are breastfeeding, you may postpone breastfeeding for 12 hours after treatment to avoid exposure in your baby.
The use of MAXALT MELT oral lyophilisates in children under 18 years of age is not recommended.
There have been no full studies to look at how safe and effective MAXALT MELT is amongst patients older than 65 years.
You may feel sleepy or dizzy while taking MAXALT MELT. If this happens, do not drive or use any tools or machines.
This medicine contains 3.75 mg aspartame in each 10 mg oral lyophilisate which is equivalent to 2.1 mg phenylalanine.
Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.
MAXALT MELT is used to treat migraine attacks. Take MAXALT MELT as soon as possible after your migraine headache has started. Do not use it to prevent an attack.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The usual dose is 10 mg.
If you are currently taking propranolol or have kidney or liver problems you should use the 5-mg dose of MAXALT MELT. You should leave at least 2 hours between taking propranolol and MAXALT MELT up to a maximum of 2 doses in a 24-hour period.
In some patients, migraine symptoms can return within a 24-hour period. If your migraine does return you can take an additional dose of MAXALT MELT. You should always wait at least 2 hours between doses.
If you do not respond to the first dose of MAXALT MELT during an attack, you should not take a second dose of MAXALT MELT for treatment of the same attack. It is still likely, however, that you will respond to MAXALT MELT during the next attack.
Do not take more than 2 doses of MAXALT MELT in a 24-hour period, (for example, do not take more than two 10 mg oral lyophilisates or more than two 10 mg or 5 mg tablets in a 24-hour period). You should always wait at least 2 hours between doses.
If your condition worsens, seek medical attention.
MAXALT MELT is also available as a tablet to be taken with liquids.
If you take more MAXALT MELT than you should, talk to your doctor or pharmacist straight away. Take the medicine pack with you.
Signs of overdosage can include dizziness, drowsiness, vomiting, fainting and slow heart rate.
If you have any further questions on the use of this product ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine.
In adult studies, the most common side effects reported were dizziness, sleepiness and tiredness.
Common (affects 1 to 10 users in 100)
Uncommon (affects 1 to 10 users in 1000)
Rare (affects 1 to 10 users in 10,000)
Not known (frequency cannot be estimated from the available data):
Tell your doctor right away if you have symptoms of allergic reactions, serotonin syndrome, heart attack or stroke.
In addition, tell your doctor if you experience any symptoms that suggest an allergic reaction (such as a rash or itching) after taking MAXALT MELT.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton/carry case/sachet/blister after "EXP". The expiry date refers to the last day of the month.
Do not store MAXALT MELT oral lyophilisates above 30°C.
Store in the original packaging in order to protect from moisture.
Do not remove the oral lyophilisate blister from the outer aluminium sachet until you are ready to take the medicine inside. Do not use the medicine if you notice that the aluminium sachet is damaged.
Always keep the aluminium sachets in the carrying case.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance of the MAXALT MELT is rizatriptan. One oral lyophilisate contains 10 mg rizatriptan as 14.53 mg of rizatriptan benzoate.
The other ingredients of MAXALT MELT oral lyophilisates are: gelatin, mannitol (E421), glycine, aspartame (E951) and peppermint flavour (composed of peppermint oil, maltodextrin and dextrin).
10 mg oral lyophilisates are white to off-white, round with a modified square on one side, with a peppermint flavour.
Pack sizes: Packs with 2, 3, 6, 12 or 18 oral lyophilisates.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufacturer
This medicinal product is authorised in the Member States of the EEA under the following names:
Austria, Finland, Sweden MAXALT RAPITAB
Belgium, Luxemburg MAXALT LYO 10 mg
Denmark MAXALT Smelt, smeltetabletter
France MAXALTLYO
Germany MAXALT lingua 10 mg Schmelztabletten
Greece MAXALT Rapid Sol. Tab.
Iceland MAXALT SMELT 10 mg frostþurrkaðar töflur
Ireland Rizatriptan MSD 10 mg oral lyophilisates
Italy MAXALT RPD 10 mg liofilizzato orale
Lithuania MAXALT 10 mg geriamieji liofilizatai
Norway Maxalt Rapitab
Romania Maxalt 10mg liofilizat oral
Spain MAXALT MAX 10 mg
The Netherlands MAXALT SMELT
United Kingdom MAXALT MELT
This leaflet was last revised in May 2024.
How can you obtain more information about MAXALT MELT?
This leaflet gives you some of the most important information about MAXALT MELT. If you have any questions after you have read it, ask your doctor or pharmacist who can give you further information.
Further information about migraine is available from the following organisations:
and
(Migraine Action Association and The Migraine Trust are independent organisations and are not associated with Organon Pharma (UK) Limited.)
© 2024 Organon group of companies. All rights reserved.
PIL.MXTM.24.UK.0283.IA-PSUSA_082.RCN004006